STOCK TITAN

Driehaus exits Korro Bio (KRRO) stake in amended 13G/A filing

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Driehaus Capital Management LLC has amended its ownership report for Korro Bio, Inc., stating that it now beneficially owns 0 shares of Korro Bio common stock, representing 0% of the class as of 12/31/2025. The filer confirms it holds no sole or shared voting or dispositive power over any Korro Bio shares and notes this is an exit filing indicating ownership of 5 percent or less of the company’s common stock.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Exit Filing


SCHEDULE 13G



DRIEHAUS CAPITAL MANAGEMENT LLC
Signature:Janet McWilliams
Name/Title:Janet McWilliams, General Counsel
Date:02/17/2026

FAQ

What does Korro Bio (KRRO) disclose in this Schedule 13G/A?

The filing shows Driehaus Capital Management LLC now reports owning 0 shares of Korro Bio common stock, representing 0% of the class as of December 31, 2025, indicating it no longer holds a reportable ownership stake.

Who is the reporting person in Korro Bio (KRRO)'s Schedule 13G/A?

The reporting person is Driehaus Capital Management LLC, organized in Delaware with a principal office at 25 East Erie Street, Chicago, Illinois 60611. It previously reported holdings in Korro Bio but now reports no beneficial ownership.

What ownership level does Driehaus report in Korro Bio (KRRO)?

Driehaus Capital Management LLC reports beneficial ownership of 0 shares of Korro Bio common stock, equal to 0% of the outstanding class. It also reports zero sole or shared voting and dispositive power over any Korro Bio shares.

What does “Ownership of 5 percent or less” mean for Korro Bio (KRRO)?

The filing states “Ownership of 5 percent or less of a class,” meaning Driehaus Capital Management LLC no longer holds at least 5% of Korro Bio’s common stock, and therefore reports its position as an exit filing with 0% beneficial ownership.

When did the ownership change triggering this Korro Bio (KRRO) filing occur?

The date of the event requiring the statement is December 31, 2025. As of that date, Driehaus Capital Management LLC reports that it beneficially owns no Korro Bio common shares and has no voting or dispositive power over any shares.

How does Driehaus describe the purpose of its Korro Bio (KRRO) holdings?

Driehaus certifies the securities referenced were acquired and held in the ordinary course of business, not to change or influence control of Korro Bio, and not in connection with any control-related transaction, other than activities solely tied to a nomination under Rule 240.14a-11.
Korro Bio, Inc.

NASDAQ:KRRO

KRRO Rankings

KRRO Latest News

KRRO Latest SEC Filings

KRRO Stock Data

105.80M
8.66M
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE